Objective: 2-[F]fluoro-2-deoxy-D-glucose positron emission tomography ([F]-FDG-PET) is a imaging modality that has been used to measure of glucose metabolism in the brain in Alzheimer's disease (AD). Clinically, decreased glucose uptake has been reported in the brain of AD, although the precise underlying mechanisms have not yet been elucidated. To elucidate the mechanisms of decreased [F]-FDG uptake in the AD by PET, [F]-FDG uptake in the brain of aged model mouse of AD was investigated using a dynamic autoradiography technique "bioradiography".
View Article and Find Full Text PDF